PortfoliosLab logoPortfoliosLab logo
LTRN vs. DVLT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

LTRN vs. DVLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantern Pharma Inc. (LTRN) and Datavault AI Inc (DVLT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

LTRN vs. DVLT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LTRN
Lantern Pharma Inc.
-53.14%-5.02%-25.47%-29.14%-24.31%-58.55%28.76%
DVLT
Datavault AI Inc
7.53%-68.19%-88.31%-98.92%-92.24%-60.73%57.33%

Fundamentals

EPS

LTRN:

-$1.75

DVLT:

-$1.02

Total Revenue (TTM)

LTRN:

$0.00

DVLT:

$6.17M

Gross Profit (TTM)

LTRN:

-$55.33K

DVLT:

$421.00K

EBITDA (TTM)

LTRN:

-$19.41M

DVLT:

-$60.36M

Returns By Period

In the year-to-date period, LTRN achieves a -53.14% return, which is significantly lower than DVLT's 7.53% return.


LTRN

1D
3.65%
1M
-47.01%
YTD
-53.14%
6M
-65.53%
1Y
-57.10%
3Y*
-33.51%
5Y*
-41.02%
10Y*

DVLT

1D
9.72%
1M
-0.21%
YTD
7.53%
6M
-48.44%
1Y
-12.25%
3Y*
-85.64%
5Y*
-89.13%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Lantern Pharma Inc.

Datavault AI Inc

Return for Risk

LTRN vs. DVLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LTRN
LTRN Risk / Return Rank: 1313
Overall Rank
LTRN Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
LTRN Sortino Ratio Rank: 1818
Sortino Ratio Rank
LTRN Omega Ratio Rank: 1818
Omega Ratio Rank
LTRN Calmar Ratio Rank: 1414
Calmar Ratio Rank
LTRN Martin Ratio Rank: 22
Martin Ratio Rank

DVLT
DVLT Risk / Return Rank: 4848
Overall Rank
DVLT Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
DVLT Sortino Ratio Rank: 7171
Sortino Ratio Rank
DVLT Omega Ratio Rank: 6262
Omega Ratio Rank
DVLT Calmar Ratio Rank: 3434
Calmar Ratio Rank
DVLT Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LTRN vs. DVLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and Datavault AI Inc (DVLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LTRNDVLTDifference

Sharpe ratio

Return per unit of total volatility

-0.62

-0.06

-0.56

Sortino ratio

Return per unit of downside risk

-0.53

1.72

-2.26

Omega ratio

Gain probability vs. loss probability

0.93

1.18

-0.25

Calmar ratio

Return relative to maximum drawdown

-0.76

-0.21

-0.55

Martin ratio

Return relative to average drawdown

-1.89

-0.33

-1.56

LTRN vs. DVLT - Sharpe Ratio Comparison

The current LTRN Sharpe Ratio is -0.62, which is lower than the DVLT Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of LTRN and DVLT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


LTRNDVLTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.62

-0.06

-0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.50

-0.46

-0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.40

-0.51

+0.11

Correlation

The correlation between LTRN and DVLT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

LTRN vs. DVLT - Dividend Comparison

Neither LTRN nor DVLT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LTRN vs. DVLT - Drawdown Comparison

The maximum LTRN drawdown since its inception was -94.89%, smaller than the maximum DVLT drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LTRN and DVLT.


Loading graphics...

Drawdown Indicators


LTRNDVLTDifference

Max Drawdown

Largest peak-to-trough decline

-94.89%

-100.00%

+5.11%

Max Drawdown (1Y)

Largest decline over 1 year

-78.95%

-84.90%

+5.95%

Max Drawdown (5Y)

Largest decline over 5 years

-94.37%

-100.00%

+5.63%

Current Drawdown

Current decline from peak

-93.52%

-100.00%

+6.48%

Average Drawdown

Average peak-to-trough decline

-65.55%

-90.29%

+24.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.71%

52.73%

-21.02%

Volatility

LTRN vs. DVLT - Volatility Comparison

Lantern Pharma Inc. (LTRN) has a higher volatility of 65.87% compared to Datavault AI Inc (DVLT) at 37.95%. This indicates that LTRN's price experiences larger fluctuations and is considered to be riskier than DVLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


LTRNDVLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

65.87%

37.95%

+27.92%

Volatility (6M)

Calculated over the trailing 6-month period

80.20%

146.87%

-66.67%

Volatility (1Y)

Calculated over the trailing 1-year period

92.57%

204.81%

-112.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.11%

192.41%

-109.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.75%

167.53%

-83.78%

Financials

LTRN vs. DVLT - Financials Comparison

This section allows you to compare key financial metrics between Lantern Pharma Inc. and Datavault AI Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00K1.00M1.50M2.00M2.50M3.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJuly0
2.90M
(LTRN) Total Revenue
(DVLT) Total Revenue
Values in USD except per share items